Biosynthesis and immunobiochemical characterization of gp17/GCDFP‐15
Open Access
- 1 October 1999
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 265 (2) , 664-670
- https://doi.org/10.1046/j.1432-1327.1999.00758.x
Abstract
The gp17 factor is a secretory product of human seminal vesicle cells which binds to CD4 and acts as a potent inhibitor of T lymphocyte apoptosis induced by CD4 crosslinking and subsequent T‐cell receptor (TCR) activation. The protein is identical to gross cystic disease fluid protein‐15 (GCDFP‐15), a breast tumor secretory marker PIP (prolactin inducible protein), a prolactin‐controlled and androgen‐controlled protein; secretory actin binding protein (SABP), a seminal plasma actin binding protein and extra‐parotid glycoprotein (EP‐GP), a secretory protein from the salivary gland. The structure of this protein has not yet been elucidated and no biological function has been clearly attributed to date. Expression of recombinant gp17/GCDFP‐15 cDNA in bacteria and insect cells leads to the production of a misfolded insoluble protein. In this study, we describe the production of gp17/GCDFP‐15 in two different eukaryotic systems, namely HeLa cells and the Pichia pastoris yeast. Using constructs in which gp17/GCDFP‐15 was tagged with enhanced green fluorescent protein (EGFP) in various combinations, we observed expression only when the fusion protein was directed to the secretory compartment by the correct signal peptide. The resulting fluorescent protein was inefficiently secreted, thus suggesting that gp17/GCDFP‐15 is not appropriately post‐translationally processed and/or transported in HeLa cells. The use of the P. pastoris secretory pathway allowed instead the accumulation in the culture medium of a GCDFP‐15/gp17 species which retained the ability to bind to CD4 and also most of the biochemical and immunological properties of the native protein. The production of an active recombinant molecule opens the way to correlate the structural properties of this peculiar factor to its ability to bind several proteins, including CD4, and to block CD4‐mediated T cell programmed death.Keywords
This publication has 19 references indexed in Scilit:
- Surface Plasmon Resonance Analysis of gp17, a Natural CD4 Ligand from Human Seminal Plasma Inhibiting Human Immunodeficiency Virus Type‐1 gp120‐Mediated Syncytium FormationEuropean Journal of Biochemistry, 1997
- In Vivo Binding of the Salivary Glycoprotein EP-GP (Identical to GCDFP-15) to Oral and Non-Oral Bacteria Detection and Identification of EP-GP Binding SpeciesBiological Chemistry, 1997
- EP-GP and the Lipocalin VEGh, Two Different Human Salivary 20-kDa ProteinsJournal of Dental Research, 1995
- Visualization of protein transport along the secretory pathway using green fluorescent proteinFEBS Letters, 1995
- Identity of Human Extra Parotid Glycoprotein (EP-GP) with Secretory Actin Binding Protein (SABP) and Its Biological PropertiesBiological Chemistry Hoppe-Seyler, 1994
- Interaction of seminal plasma proteins with cell surface antigens: Presence of a CD4-binding glycoprotein in human seminal plasmaExperimental Cell Research, 1991
- The prolactin-inducible protein (PIP/GCDFP-15) gene: Cloning, structure and regulationMolecular and Cellular Endocrinology, 1991
- Primary structure of a new actin‐binding protein from human seminal plasmaEuropean Journal of Biochemistry, 1991
- Isolation of a new actin-binding protein from human seminal plasmaBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970